JAN 14

Understanding and Implementing a Pharmaceutical Quality by Design Program


All other Events(no CPF)




  14 Jan 2020 through 14 Jan 2020


  Online Event

Website URL:


Sponsoring organization:

  Training Doyens


  Medicine & Health > Pharmaceutical/Medicinal

Event description:

OVERVIEW The benefits of applying the QbD principles in the pharmaceutical industry have been well advertised. Most important are the direct benefits to our primary customer; the patient. Per Janet Woodcock M.D. Director, Center for Drug Evaluation and Research (CDER), Food and Drug Administration “All products are designed and developed to be of high quality; Quality by Design provides a structured framework for developing, documenting and presenting development rationale, experience and knowledge of the formulation and the process, and to ensure manufacture of products consistently fit for patient use.” Application of these principles can also benefit the pharmaceutical companies by improving manufacturing efficiency and promoting innovation. WHY SHOULD YOU ATTEND However, implementing these principles into the pharmaceutical development culture can be challenging. QbD involves a complex set of interactions, technologies and systems that are not easy to grasp. This quality by design training will explain the main principles behind a QbD approach and provide guidelines on how to implement the concepts into a pharmaceutical development organization. Topics covered will include the target product quality profile, risk assessment, methods to establish a design space, and design of a control strategy. This review will help bridge the gap between understanding the principles and practical application. AREAS COVERED • Quality Target Product Profile (QTPP) • Risk Assessment • Using Models • Design of Experiments • Developing a Design Space • Process Analytical Technology (PAT) • FMEA and Control Plan • Target Operational Profile • Control Strategy LEARNING OBJECTIVES This training will explain the main principles behind a QbD (Quality by Design) approach and provide guidelines on how to implement the concepts into a pharmaceutical development organization. WHO WILL BENEFIT This course is designed for people tasked with developing, filing, and manufacturing pharmaceutical products especially small molecule oral dosage forms. This includes individuals that have responsibilities for formulation development, scale-up, filing, and commercial manufacture of dosage forms as well as maintaining the high quality of those products. Following personnel will benefit from the course: • Senior Quality Managers • Quality Professionals • Regulatory Professionals • Compliance Professionals • Production Supervisors • Manufacturing Engineers • Production Engineers • Process Owners • Quality Engineers • Quality Auditors • Development Professionals • Senior Development Managers SPEAKER Steven Laurenz, Principal Consultant – BioPhia Consulting Inc., has over 25 years of technical leadership experience in product development, process development, technology transfer, and process optimization. He is skilled in taking new products from early laboratory stage to successful manufacturing launch. Use Promo Code XMSNY19 and get flat 20% discount on all purchases. To Register (or) for more details please click on this below link: http://bit.ly/2YR1Ua7 Email: support@trainingdoyens.com Toll Free: +1-888-300-8494 Tel: +1-720-996-1616 Fax: +1-888-909-1882

Posting date:

16 December 2019
views | Be the first to rate this event


Not-featured (How do I make my event featured?)